Published in Infect Immun on April 01, 1992
Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41
Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O. Infect Immun (1994) 3.27
Regulation of the prfA transcriptional activator of Listeria monocytogenes: multiple promoter elements contribute to intracellular growth and cell-to-cell spread. Infect Immun (1993) 2.49
Variation in biofilm formation among strains of Listeria monocytogenes. Appl Environ Microbiol (2003) 2.26
Listeria monocytogenes regulates flagellar motility gene expression through MogR, a transcriptional repressor required for virulence. Proc Natl Acad Sci U S A (2004) 2.14
GILT is a critical host factor for Listeria monocytogenes infection. Nature (2008) 2.12
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1996) 1.76
Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect Immun (1998) 1.50
The MogR transcriptional repressor regulates nonhierarchal expression of flagellar motility genes and virulence in Listeria monocytogenes. PLoS Pathog (2006) 1.41
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J Exp Med (1994) 1.34
Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants. Infect Immun (2004) 1.34
Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect Immun (2002) 1.33
Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Infect Immun (2006) 1.29
Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother (1999) 1.15
RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J (2012) 1.14
Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants. Infect Immun (1994) 1.07
Identification of Listeria monocytogenes in vivo-induced genes by fluorescence-activated cell sorting. Infect Immun (2001) 1.04
Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response. Infect Immun (1999) 0.98
Conditional lethality yields a new vaccine strain of Listeria monocytogenes for the induction of cell-mediated immunity. Infect Immun (2005) 0.95
Distinct responses of splenic dendritic cell subsets to infection with Listeria monocytogenes: maturation phenotype, level of infection, and T cell priming capacity ex vivo. Cell Immunol (2011) 0.94
Lack of expansion of major histocompatibility complex class Ib-restricted effector cells following recovery from secondary infection with the intracellular pathogen Listeria monocytogenes. Infect Immun (2001) 0.88
Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances. Ther Adv Vaccines (2014) 0.86
The roles of IL-12 and IL-23 in CD8+ T cell-mediated immunity against Listeria monocytogenes: Insights from a DC vaccination model. Cell Immunol (2010) 0.86
Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product. Infect Immun (2005) 0.84
Definition of genetically distinct attenuation mechanisms in naturally virulence-attenuated Listeria monocytogenes by comparative cell culture and molecular characterization. Appl Environ Microbiol (2005) 0.84
Cytotoxic-T-lymphocyte responses to epitopes of listeriolysin O and p60 following infection with Listeria monocytogenes. Infect Immun (1996) 0.83
A critical role for phospholipase C in protective immunity conferred by listeriolysin O-deficient Listeria monocytogenes. Microb Pathog (2007) 0.83
Recombinant Listeria monocytogenes expressing a cell wall-associated listeriolysin O is weakly virulent but immunogenic. Infect Immun (2009) 0.81
Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines. Hum Vaccin Immunother (2013) 0.80
In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain. Infect Immun (2011) 0.79
DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein. Infect Immun (2003) 0.79
Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus. PLoS One (2012) 0.78
Elimination of the listeriolysin O-directed immune response by conservative alteration of the immunodominant listeriolysin O amino acid 91 to 99 epitope. Infect Immun (1996) 0.78
Priming of protective anti-Listeria monocytogenes memory CD8+ T cells requires a functional SecA2 secretion system. Infect Immun (2011) 0.78
Cellular resistance to infection. J Exp Med (1962) 30.96
Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol (1989) 15.41
Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med (1988) 12.95
In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun (1987) 11.24
Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect Immun (1986) 10.02
The role of cell-mediated immunity in bacterial infections. Rev Infect Dis (1982) 9.26
Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med (1972) 8.25
Tn916-induced mutations in the hemolysin determinant affecting virulence of Listeria monocytogenes. J Bacteriol (1987) 7.18
Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements. J Immunol (1987) 6.75
Immunization studies on listeriosis in mice. J Immunol (1957) 6.48
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47
Cellular mediators of anti-Listeria immunity as an enlarged population of short lived, replicating T cells. Kinetics of their production. J Exp Med (1973) 5.94
Intracellular and cell-to-cell spread of Listeria monocytogenes involves interaction with F-actin in the enterocytelike cell line Caco-2. Infect Immun (1990) 5.84
Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun (1992) 5.81
Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly. Proc Natl Acad Sci U S A (1990) 5.45
THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES. J Exp Med (1964) 5.08
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Isolation of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect Immun (1990) 4.74
Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature (1990) 4.58
Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of listeria monocytogenes. Proc Natl Acad Sci U S A (1990) 4.52
The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84
Pleiotropic control of Listeria monocytogenes virulence factors by a gene that is autoregulated. Mol Microbiol (1991) 3.73
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J Exp Med (1979) 3.31
Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J Immunol (1987) 2.90
Listeria monocytogenes mutants lacking phosphatidylinositol-specific phospholipase C are avirulent. J Exp Med (1991) 2.85
Effective protection against Listeria monocytogenes and delayed-type hypersensitivity to listerial antigens depend on cooperation between specific L3T4+ and Lyt 2+ T cells. Infect Immun (1985) 2.70
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells. J Exp Med (1986) 2.42
Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature (1982) 2.38
Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur J Immunol (1983) 2.06
Inflammatory lymphocyte in cell-mediated antibacterial immunity: factors governing the accumulation of mediator T cells in peritoneal exudates. Infect Immun (1974) 2.02
Acquired resistance to facultative intracellular bacteria: relationship between persistence, cross-reactivity at the T-cell level, and capacity to stimulate cellular immunity of different Listeria strains. Infect Immun (1984) 1.96
Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity. J Immunol (1988) 1.89
Dual regulation of anti-bacterial resistance and inflammatory neutrophil and macrophage accumulation by L3T4+ and Lyt 2+ Listeria-immune T cells. Immunology (1987) 1.76
Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets. Infect Immun (1990) 1.69
T-cell co-operation in the mediation of acquired resistance to Listeria monocytogenes. Immunology (1985) 1.21
Production of macrophage-activating and migration-inhibition factors in vitro by serologically selected and cloned Listeria monocytogenes-specific T cells of the Lyt 1+2- phenotype. Infect Immun (1984) 1.21
Lack of correlative enhancement of passive transfer of delayed-type hypersensitivity and antilisterial resistance when using concanavalin A-stimulated primed spleen cells. Infect Immun (1983) 1.13
Enumeration of Listeria monocytogenes-reactive L3T4+ T cells activated during infection. Microb Pathog (1986) 1.06
Possible role of helper and cytolytic T lymphocytes in antibacterial defense: conclusions based on a murine model of listeriosis. Rev Infect Dis (1988) 0.98
Isolation and characterization of protective T cells induced by Listeria monocytogenes. Infect Immun (1986) 0.97
Gamma interferon-mediated increase in the number of Ia-bearing macrophages during infection with Listeria monocytogenes. Infect Immun (1987) 0.83
Enhancement of passive antilisterial immunity and change of Lyt phenotype following in vitro stimulation of murine lymphoid cells from immune donors. Clin Invest Med (1984) 0.78
Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol (1989) 15.41
Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect Immun (1981) 13.80
Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med (1988) 12.95
Adoptive transfer of immunity to Listeria monocytogenes. The influence of in vitro stimulation on lymphocyte subset requirements. J Immunol (1987) 6.75
Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect Immun (1984) 6.63
The rate of actin-based motility of intracellular Listeria monocytogenes equals the rate of actin polymerization. Nature (1992) 5.84
Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol Microbiol (1993) 5.46
Listeria monocytogenes moves rapidly through the host-cell cytoplasm by inducing directional actin assembly. Proc Natl Acad Sci U S A (1990) 5.45
Virulence-associated plasmids from Yersinia enterocolitica and Yersinia pestis. J Bacteriol (1981) 5.11
Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am J Trop Med Hyg (1993) 4.75
Isolation of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect Immun (1990) 4.74
Interaction of human Arp2/3 complex and the Listeria monocytogenes ActA protein in actin filament nucleation. Science (1998) 4.74
Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature (1990) 4.58
Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun (1985) 4.36
The two distinct phospholipases C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread. Infect Immun (1995) 4.02
Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids. Infect Immun (1984) 3.98
Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg (1993) 3.69
Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proc Natl Acad Sci U S A (1993) 3.63
The interaction of bacteria with mammalian cells. Annu Rev Cell Biol (1992) 3.62
Involvement of profilin in the actin-based motility of L. monocytogenes in cells and in cell-free extracts. Cell (1994) 3.42
Characterization of Listeria monocytogenes pathogenesis in a strain expressing perfringolysin O in place of listeriolysin O. Infect Immun (1994) 3.27
Role of a plasmid in the pathogenicity of Yersinia species. Curr Top Microbiol Immunol (1985) 3.13
Genetic analysis of essential plasmid determinants of pathogenicity in Yersinia pestis. J Infect Dis (1983) 2.95
Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science (1986) 2.89
Listeria monocytogenes mutants lacking phosphatidylinositol-specific phospholipase C are avirulent. J Exp Med (1991) 2.85
Actin filament nucleation by the bacterial pathogen, Listeria monocytogenes. J Cell Biol (1990) 2.54
Presentation of Listeria monocytogenes to CD8+ T cells requires secretion of hemolysin and intracellular bacterial growth. J Immunol (1990) 2.54
A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity. Science (2000) 2.51
Regulation of the prfA transcriptional activator of Listeria monocytogenes: multiple promoter elements contribute to intracellular growth and cell-to-cell spread. Infect Immun (1993) 2.49
The broad-range phospholipase C and a metalloprotease mediate listeriolysin O-independent escape of Listeria monocytogenes from a primary vacuole in human epithelial cells. Infect Immun (1995) 2.30
Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat Med (2005) 2.28
Transfer of the virulence plasmid of Yersinia pestis to Yersinia pseudotuberculosis. Infect Immun (1985) 2.24
In vitro evaluation of immunity to Coxiella burnetii. J Immunol (1976) 2.22
Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants. Infect Immun (1993) 2.20
Cloning and characterization of a mouse cysteine proteinase. J Biol Chem (1986) 2.12
Three regions within ActA promote Arp2/3 complex-mediated actin nucleation and Listeria monocytogenes motility. J Cell Biol (2000) 2.03
Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes. Infect Immun (2000) 1.87
Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect Immun (1999) 1.83
Intracellular methicillin selection of Listeria monocytogenes mutants unable to replicate in a macrophage cell line. Proc Natl Acad Sci U S A (1989) 1.82
Asymmetric distribution of the Listeria monocytogenes ActA protein is required and sufficient to direct actin-based motility. Mol Microbiol (1995) 1.71
Development of a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice. Infect Immun (2001) 1.70
Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets. Infect Immun (1990) 1.69
Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility. J Cell Biol (2001) 1.68
Detection of Plasmodium falciparum infection with the fluorescent dye, benzothiocarboxypurine. Am J Trop Med Hyg (1991) 1.65
Dual promoters of the Listeria monocytogenes prfA transcriptional activator appear essential in vitro but are redundant in vivo. Mol Microbiol (1994) 1.62
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology (1999) 1.59
Detection of long-term cellular immunity to Coxiella burneti as assayed by lymphocyte transformation. Infect Immun (1975) 1.55
Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect Immun (1998) 1.50
Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J Biol Chem (1996) 1.49
Transcriptional activation of the Listeria monocytogenes hemolysin gene in Bacillus subtilis. J Bacteriol (1992) 1.49
Proteolytic pathways of activation and degradation of a bacterial phospholipase C during intracellular infection by Listeria monocytogenes. J Cell Biol (1997) 1.48
Listeriolysin O is a target of the immune response to Listeria monocytogenes. J Exp Med (1992) 1.42
Cloning of a gene encoding a major secreted polypeptide of Listeria monocytogenes and its potential use as a species-specific probe. Appl Environ Microbiol (1989) 1.39
Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J Exp Med (1994) 1.34
MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J Immunol (1997) 1.26
Enhanced adoptive transfer of immunity to Listeria monocytogenes after in vitro culture of murine spleen cells with concanavalin A. Infect Immun (1982) 1.25
Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol (1992) 1.24
Intracellular growth of bacteria. Methods Enzymol (1994) 1.22
Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol Microbiol (1999) 1.22
Systematic mutational analysis of the amino-terminal domain of the Listeria monocytogenes ActA protein reveals novel functions in actin-based motility. Mol Microbiol (2001) 1.16
Role of antibody in Coxiella burnetii infection. Infect Immun (1981) 1.13
Lack of correlative enhancement of passive transfer of delayed-type hypersensitivity and antilisterial resistance when using concanavalin A-stimulated primed spleen cells. Infect Immun (1983) 1.13
The cellular immune response to antigens of Coxiella burneti. Can J Microbiol (1974) 1.11
Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants. Infect Immun (1994) 1.07
Kinetics and maintenance of acquired resistance in mice to Listeria monocytogenes. Infect Immun (1977) 1.06
Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen. Mol Microbiol (1996) 1.04
Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccine (1997) 1.00
Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. J Immunol (1981) 1.00
Potentiation of the antimalarial agent rufigallol. Antimicrob Agents Chemother (1996) 0.99
Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun (1998) 0.98
Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response. Infect Immun (1999) 0.98
A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes. Infect Immun (1997) 0.98
Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. J Immunol (1999) 0.97
How the Listeria monocytogenes ActA protein converts actin polymerization into a motile force. Trends Microbiol (1997) 0.97
Heat-labile B-cell mitogen obtained from Listeria monocytogenes. Infect Immun (1978) 0.96
An H2-T MHC class Ib molecule presents Listeria monocytogenes-derived antigen to immune CD8+ cytotoxic T cells. J Immunol (1994) 0.96
Pathophysiologic features of Q fever-infected guinea pigs. Am J Vet Res (1975) 0.95
Acquired immunity to an intracellular pathogen: immunologic recognition of L. monocytogenes-infected cells. Immunol Rev (1997) 0.94
The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J Immunol (1989) 0.94
Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N-end rule pathway. Cell Microbiol (1999) 0.93
Induction of immunity with avirulent Listeria monocytogenes 19113 depends on bacterial replication. Infect Immun (1988) 0.93
Porcine neonatal survival and serum gamma globulins. J Anim Sci (1978) 0.91
Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Lett (1997) 0.91
Progressive myelopathy in older German shepherd dogs. II. Presence of circulating suppressor cells. J Immunol (1980) 0.89
The in vitro detection of antigen sensitivity in contact dermatitis by lymphocyte transformation. Cell Immunol (1975) 0.88
Cytolysins from intracellular pathogens. Trends Microbiol (1994) 0.88
Lack of expansion of major histocompatibility complex class Ib-restricted effector cells following recovery from secondary infection with the intracellular pathogen Listeria monocytogenes. Infect Immun (2001) 0.88
Progressive myelopathy in older German shepherd dogs. I. Depressed response to thymus-dependent mitogens. J Immunol (1980) 0.88
The influence of cyclosporin A on the development of actively induced and passively transferred experimental allergic encephalomyelitis. Cell Immunol (1983) 0.87
Potentiation of an antimalarial oxidant drug. Antimicrob Agents Chemother (1997) 0.87
Suppressor cell infleunce in selected strains of inbred rats. II. Macrophage-associated suppression of cell-mediated immune responsiveness. Cell Immunol (1977) 0.86
Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell Immunol (1991) 0.85
Small plaque mutants. Methods Enzymol (1994) 0.85